文献速递关节外科

全关节置换术前使用远程营养师与移动应用程序减重:一项多中心随机对照试验

Weight Loss Before Total Joint Arthroplasty Using a Remote Dietitian and a Mobile Application: A Multicenter Randomized Controlled Trial.
PubMed 文献 · J Bone Joint Surg Am · 2025-03-20

该多中心随机对照试验纳入60例BMI 40至47 kg/m²、拟行初次全髋或全膝关节置换术的重度肥胖患者,比较远程营养师联合移动应用程序与标准护理的术前12周减重效果。干预组减重-4.1 kg vs 对照组-2.1 kg(p=0.22),BMI降幅-1.4 vs -0.9 kg/m²(p=0.36),差异均未达统计学显著。作者认为该干预可行且受患者好评,但可能需要更强化的干预才能实现有临床意义的减重。

要点

  • 远程营养师联合移动应用程序术前减重可行且83%患者认为视频通话有帮助。
  • 干预组减重-4.1 kg vs 对照组-2.1 kg(p=0.22),差异未达统计学显著。
  • 两组并发症无差异,对照组发生1例髌骨骨折,干预组发生1例深静脉血栓栓塞。

核心结论

  • 使用营养师和移动应用程序的术前减重干预可行,且患者评价良好。
  • 远程营养师和移动应用程序可能弥补全关节置换术前肥胖治疗可及性的缺口。
  • 干预组减重更多且更可能达到BMI<40 kg/m²,但差异未达统计学显著。
  • 可能需要更强化的干预才能实现足以带来全关节置换术临床重要改善的减重。

研究设计与样本

  • 多中心随机对照试验,纳入60例BMI 40至47 kg/m²、2019年9月至2023年1月期间预约初次全髋或全膝关节置换术的患者。
  • 平均年龄61岁,67%为女性,平均BMI 44 kg/m²;对照组29例接受标准护理,干预组31例术前12周完成营养师视频通话并使用移动应用程序。
  • 基线和12周收集体重与问卷,随访率87%;平均随访1.8年。
  • 比较减重、患者报告结局、并发症、翻修和再手术。
  • 证据等级:治疗性I级。

主要发现

  • 干预组减重-4.1 kg vs 对照组-2.1 kg(p=0.22),差异未达统计学显著。
  • 干预组BMI降幅-1.4 kg/m² vs 对照组-0.9 kg/m²(p=0.36),差异未达统计学显著。
  • 干预组达到BMI<40 kg/m²的比值比为1.9(p=0.44),未达统计学显著。
  • 髋关节功能障碍与骨关节炎结局评分、膝关节损伤与骨关节炎结局评分及下肢活动量表评分的平均变化无显著差异。
  • 基线时仅11%在过去3个月内看过营养师;83%的受试者认为视频通话有帮助;两组并发症无差异,对照组发生1例髌骨骨折,干预组发生1例深静脉血栓栓塞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 干预组减重更多且更可能达到BMI<40 kg/m²,但差异未达统计学显著。
  • 作者结论指出可能需要更强化的干预才能实现足以带来全关节置换术临床重要改善的减重。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many surgeons recommend weight loss for patients with obesity before total joint arthroplasty (TJA), but few studies have evaluated weight loss interventions. This study compared weight loss using a remote dietitian and a mobile application (app) with weight loss using standard care for patients with severe obesity before TJA. METHODS: This multicenter randomized controlled trial included 60 subjects with a body mass index (BMI) of 40 to 47 kg/m 2 who had been scheduled for primary total hip or knee arthroplasty from September 2019 to January 2023. The mean age was 61 years, 67% were women, and the mean BMI was 44 kg/m 2 . The control subjects (n = 29) received standard care; the intervention subjects (n = 31) completed video calls with dietitians and used a mobile app for 12 weeks preoperatively. Weights and surveys were collected at baseline and 12 weeks, with 87% follow-up. Weight loss, patient-reported outcomes, complications, revisions, and reoperations were compared. The mean follow-up was 1.8 years. RESULTS: The intervention subjects lost more weight (-4.1 versus -2.1 kg, p = 0.22) and had larger decreases in BMI (-1.4 versus -0.9 kg/m 2 , p = 0.36 than the controls, but not significantly so. The intervention subjects had higher odds of achieving a BMI of <40 kg/m 2 (odds ratio = 1.9, p = 0.44), but not significantly so. There were no significant differences in the mean change in the Hip disability and Osteoarthritis Outcome Score, the Knee injury and Osteoarthritis Outcome Score, or the Lower Extremity Activity Scale score. At baseline, only 11% had seen a dietitian in the last 3 months. Most subjects (83%) felt that video calls were helpful. There were no differences in complications between the groups; there was a patellar fracture in the control group and a deep venous thromboembolism in the intervention group. CONCLUSIONS: A preoperative weight loss intervention using a dietitian and a mobile app was feasible and viewed favorably among patients. Remote dietitians and mobile apps may address gaps in access to obesity treatment before TJA. While the intervention subjects lost more weight and were more likely to achieve a BMI of <40 kg/m 2 , the differences were not significant. More intensive interventions may be needed to achieve enough weight loss for clinically important improvements in TJA. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Seward MW, Liimakka AP, Jamison MP, et al. Weight Loss Before Total Joint Arthroplasty Using a Remote Dietitian and a Mobile Application: A Multicenter Randomized Controlled Trial. J Bone Joint Surg Am. 2025. PMID: 40112039. doi:10.2106/JBJS.24.00838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。